Australia Radiation Oncology Market Size & Outlook
Australia radiation oncology market, 2017-2028 (US$M)
Related Markets
Australia radiation oncology market highlights
- The Australia radiation oncology market generated a revenue of USD 156.0 million in 2020 and is expected to reach USD 283.1 million by 2028.
- The Australia market is expected to grow at a CAGR of 7.7% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Radiation oncology market data book summary
| Market revenue in 2020 | USD 156.0 million |
| Market revenue in 2028 | USD 283.1 million |
| Growth rate | 7.7% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, Australia accounted for 2.1% of the global radiation oncology market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, China radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 532.9 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 72.82% in 2020. Horizon Databook has segmented the Australia radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
High incidence of cancer is anticipated to boost market growth over the forecast period. According to Australian Institute of Health and Welfare (AIWH), the age-standardized rate of new cancer cases in Australia was projected to reach 483 cases per 100,000 people.
Whereas cancerrelated deaths are expected to reach to 159 per 100,000 people, by the end of 2019. Increasing adoption of radiotherapy and growing awareness among people about the benefits of cancer treatment with radiotherapy are expected to drive market growth.
As per the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), every year, over 60,000 Australians opt for radiation therapy to treat cancer. Increase in the number of installed units is expected to drive market growth over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia radiation oncology market size, by type, 2017-2028 (US$M)
Australia Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
